Santhera Pharmaceuticals Holding AG (SPHDF)
USD 17.01
(5.0%)
USD 17.01
(5.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 65.13 Million USD | 171.27% |
| 2022 | -76.86 Million USD | -26.29% |
| 2021 | -60.86 Million USD | 20.49% |
| 2020 | -76.54 Million USD | -290.66% |
| 2019 | -19.59 Million USD | 64.35% |
| 2018 | -54.96 Million USD | -3.94% |
| 2017 | -52.88 Million USD | -51.76% |
| 2016 | -34.84 Million USD | -686.32% |
| 2015 | 5.94 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -8.49 Million USD | -0.4% |
| 2024 Q1 | -8.46 Million USD | -109.12% |
| 2023 Q2 | -26.05 Million USD | -104.31% |
| 2023 FY | 54.78 Million USD | 171.27% |
| 2023 Q1 | -12.75 Million USD | 71.48% |
| 2023 Q3 | 42.66 Million USD | 263.74% |
| 2023 Q4 | 92.78 Million USD | 117.45% |
| 2022 Q2 | -31.08 Million USD | 0.0% |
| 2022 Q4 | -44.71 Million USD | -113.4% |
| 2022 FY | -76.86 Million USD | -26.29% |
| 2022 Q3 | -20.95 Million USD | 32.59% |
| 2021 Q2 | -22.19 Million USD | 0.0% |
| 2021 FY | -60.86 Million USD | 20.49% |
| 2021 Q4 | -38.37 Million USD | 0.0% |
| 2020 Q2 | -33.58 Million USD | 0.0% |
| 2020 FY | -76.54 Million USD | -290.66% |
| 2020 Q4 | -40.53 Million USD | 0.0% |
| 2019 FY | -19.59 Million USD | 64.35% |
| 2019 Q4 | 8.18 Million USD | 0.0% |
| 2019 Q2 | -27.58 Million USD | 0.0% |
| 2018 FY | -54.96 Million USD | -3.94% |
| 2017 FY | -52.88 Million USD | -51.76% |
| 2016 FY | -34.84 Million USD | -686.32% |
| 2015 FY | 5.94 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | 4977.296% |
| Arch Therapeutics, Inc. | -6.98 Million USD | 1032.757% |
| Evofem Biosciences, Inc. | 52.97 Million USD | -22.941% |
| Nascent Biotech, Inc. | -2.08 Million USD | 3219.868% |
| Rebus Holdings, Inc. | -1.02 Million USD | 6485.581% |
| Qrons Inc. | -789.34 Thousand USD | 8351.494% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | -632.4 Thousand USD | 10399.21% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 204.048% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | 15776.586% |
| Skye Bioscience, Inc. | -37.64 Million USD | 273.02% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 186.887% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | 1090.447% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | 23923.134% |
| SQZ Biotechnologies Company | -79.46 Million USD | 181.965% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | 2351.869% |
| Propanc Biopharma, Inc. | -1.82 Million USD | 3677.694% |
| Mesoblast Limited | -87.95 Million USD | 174.052% |
| Marizyme, Inc. | -65.34 Million USD | 199.673% |
| Genus plc | 7.9 Million USD | -724.467% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | 698.003% |
| Pharming Group N.V. | -10.54 Million USD | 717.491% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | 3101.775% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | 1855.494% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | 836.465% |
| ContraFect Corporation | -65.15 Million USD | 199.969% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | 1433.035% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | 3870.456% |
| IMV Inc. | -36.48 Million USD | 278.516% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | 908.133% |
| MultiCell Technologies, Inc. | -380.07 USD | 17137186.326% |
| ONE Bio Corp. | 8.67 Million USD | -650.672% |
| Accustem Sciences Inc. | -3.74 Million USD | 1838.538% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 226.002% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | 5240.176% |
| Q BioMed Inc. | -2.05 Million USD | 3273.975% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | 1844.788% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | 2835.677% |
| Biomind Labs Inc. | -1.21 Million USD | 5463.741% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 209.054% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | 2199.864% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | 924.145% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | 3441.437% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | 435015.358% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | 510.378% |
| Curative Biotechnology, Inc. | -5.81 Million USD | 1219.651% |
| GB Sciences, Inc. | -1.36 Million USD | 4883.287% |
| Alpha Cognition Inc. | -13.77 Million USD | 572.918% |
| HST Global, Inc. | -146.21 Thousand USD | 44647.517% |
| CSL Limited | 2.64 Billion USD | 97.535% |
| Wesana Health Holdings Inc. | -1.75 Million USD | 3811.762% |
| Halberd Corporation | -79.67 Thousand USD | 81847.231% |
| Enzolytics Inc. | -2.17 Million USD | 3092.097% |
| Agentix Corp. | -1.37 Million USD | 4839.66% |
| Resverlogix Corp. | -3.61 Million USD | 1904.236% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | 2153.736% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | -295.05 Million USD | 122.075% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | -66362.167% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | -840.603% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | 1739.392% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | 2252.347% |
| AVAX Technologies, Inc. | -6.41 Million USD | 1115.536% |
| Zenith Capital Corp. | -10.59 Million USD | 714.694% |
| Genscript Biotech Corporation | -95.47 Million USD | 168.218% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | 280338.035% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | 1671.006% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | 107863.512% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | 3348.339% |
| Kadimastem Ltd | -3.3 Million USD | 2069.31% |
| Helix BioMedix, Inc. | -1.05 Million USD | 6267.558% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | 1805.497% |
| BioStem Technologies, Inc. | -8.48 Million USD | 867.807% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | 14857.023% |
| LadRx Corporation | 400.44 Thousand USD | -16165.217% |
| Cell Source, Inc. | -5.32 Million USD | 1324.024% |
| Regen BioPharma, Inc. | 1.02 Million USD | -6263.695% |
| Regen BioPharma, Inc. | 1.02 Million USD | -6263.695% |
| NovAccess Global Inc. | -4.76 Million USD | 1465.703% |
| Affymax, Inc. | -14.42 Million USD | 551.559% |
| Itoco Inc. | -1.86 Million USD | 3584.917% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | 1566.121% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | 4002.512% |
| Mobile Lads Corp. | -2.26 Million USD | 2977.796% |
| CytoDyn Inc. | -49.84 Million USD | 230.681% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | 82512.314% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | 28651.168% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | 7017.782% |
| SYBLEU INC | -180.3 Thousand USD | 36223.948% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | 4138.658% |
| International Stem Cell Corporation | -131 Thousand USD | 49819.789% |
| Bioxytran, Inc. | -4.28 Million USD | 1621.797% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | 120112.021% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | 2674.173% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 235.49% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | 3181.028% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | -780.88 Thousand USD | 8440.89% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | 2155.964% |
| Neutra Corp. | -233.46 Thousand USD | 27998.368% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 420.994% |
| PureTech Health plc | -65.69 Million USD | 199.141% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | 406.27% |
| IXICO plc | -1.17 Million USD | 5629.111% |
| IntelGenx Technologies Corp. | -9.92 Million USD | 756.119% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 214.012% |
| CSL Limited | 2.64 Billion USD | 97.535% |
| Cellectis S.A. | -103.17 Million USD | 163.129% |